您当前的位置：
首页 >
文章列表页 >
Drug comprehensive value assessment frameworks for medical insurance：overseas experiences and implications for China
更新时间：2026-02-27

    • Drug comprehensive value assessment frameworks for medical insurance：overseas experiences and implications for China

    • “The research progress in the field of comprehensive value evaluation of medical insurance drugs was introduced, and the relevant expert system compared the comprehensive value evaluation frameworks of drugs in 11 typical countries and regions, providing decision-making references for China to build a scientific and standardized comprehensive value evaluation system for medical insurance drugs.”
    • ZHONGGUO YAOFANG   Vol. 37, Issue 4, Pages: 413-419(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.04.01    

      CLC： R95

    • Received：29 September 2025，

      Revised：2026-02-06，

      Accepted：09 February 2026，

      Published：28 February 2026

    移动端阅览

  • LIU Yijun,LI Dan,ZHANG Yu,et al.Drug comprehensive value assessment frameworks for medical insurance：overseas experiences and implications for China[J].ZHONGGUO YAOFANG,2026,37(04):413-419. DOI： 10.6039/j.issn.1001-0408.2026.04.01.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0